Sunscreen Products: VAT

James Murray Excerpts

Thursday 9th February 2023 Westminster Hall

[James Murray (Ealing North) (Lab/Co-op)]

It is a particular pleasure to serve in this debate with you, Mr Sharma, my parliamentary neighbour, as Chair. I congratulate the hon. Member for East Dunbartonshire (Amy Callaghan) on securing the debate and raising this important health issue. I am pleased to be here on behalf of the Opposition and I thank all hon. Members for their contributions. People have spoken powerfully about the impact that skin cancer can have on people’s lives, and on friends and family.

There is consensus among hon. Members present about the importance of sunscreen products and their growing importance in our lives. While these products have perhaps historically been associated more with travel to warmer climates, the past year has demonstrated how susceptible we are to heatwaves and the intense periods of direct sunlight they can bring to the UK.

I echo what other hon. Members have said today. Organisations including Cancer Research UK have long made clear that the amount of UV exposure over someone’s entire lifetime is one factor that contributes significantly to the risk of skin cancer. According to the research, melanoma is the fifth most common cancer in the UK, with 16,000 cases a year, of which almost nine in 10 cases are preventable. It is vital that people can access sunscreen products when they need them.

As we heard earlier, high factor sunscreen products are already available on the NHS prescription list for a few specific conditions, and are exempt from VAT when dispensed through pharmacies. However, we are only too aware of the crisis facing our NHS and the difficulties people can encounter trying to secure an appointment with an NHS GP. That may restrict access to prescriptions, especially in cases where a repeat prescription is not available.

In her response, it would be very helpful if the Minister could share with us any information she has on the number of people receiving sunscreen products as a prescription on the NHS, and how many receive their prescription free of charge. It would also be helpful if she could update us on the average waiting time to obtain an NHS GP appointment.  I am sure that the Minister will also set out the Government’s position in response to the call from the hon. Member for East Dunbartonshire. The Opposition appreciate that expanding the scope of VAT release is a complex consideration that can add pressures to public finances.

There is a wider point about the affordability of sunscreen and other products that consumers may need to buy, as my hon. Friend the Member for Reading East (Matt Rodda) said. As the cost of living crisis has deepened, costs for ordinary households have risen to record highs. The Office for Budget Responsibility has predicted that living standards will be worse at the end of this Parliament than they were at its start. It has also outlined that real post-tax household income is expected to fall by 4.3% in 2022-23—the biggest fall since comparable records began nearly 70 years ago.

Finally, I would be interested to hear from the Minister what discussions the Government have had with sunscreen product manufacturers and retailers to determine what steps can be taken to ensure that such products are affordable for consumers. I would be grateful if she could also set out what support those manufacturers have said they may want or need from the Government to help make sure this can be achieved.